Icatibant as acute treatment for hereditary angioedema in adults
- 13 May 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 9 (6) , 779-788
Abstract
Introduction: Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is a rare disease, characterized by recurrent, unpredictable episodes of cutaneous and/or mucosal edema. Bradykinin, released by the activation of the contact system, binds to bradykinin B2 receptors on the endothelial cell surface to enhance vascular permeaility, which leads to angioedema. Areas covered: C1-INH-HAE therapy is aimed at the inhibition of bradykinin release, as well as at the blockage of its effects mediated by its receptor. Three controlled trials, three open-label extensions, and two open-label studies, and a prospective, observational study have confirmed the safety and efficacy of the bradykinin B2 receptor antagonist, icatibant administered as acute treatment for HAE attacks in adult patients with C1-INH-HAE. Expert commentary: The ready-to-use, pre-filled syringes of icatibant can be self-administered easily, effectively, safely and, importantly, conviently. – This has resulted in patients being able to quickly treat an attack and realize a dramatic change for the better in their lives.Keywords
This publication has 77 references indexed in Scilit:
- Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupAllergy, 2014
- In vivo activation and functions of the protease factor XIIThrombosis and Haemostasis, 2014
- Current pharmacotherapy of bradykinin-mediated angioedemaExpert Opinion on Pharmacotherapy, 2013
- Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiencyClinical and Experimental Immunology, 2011
- Bradykinin and the Pathogenesis of Hereditary AngioedemaWorld Allergy Organization Journal, 2011
- HAEdb: A novel interactive, locus-specific mutation database for the C1 inhibitor geneHuman Mutation, 2004
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedemaJournal of Allergy and Clinical Immunology, 2000
- Local bradykinin generation in hereditary angioedema☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Hereditary Angioneurotic Edema: Two Genetic VariantsScience, 1965